Non-Immunotherapy Application of LNP-mRNA: Maximizing Efficacy and Safety

Lipid nanoparticle (LNP) formulated messenger RNA-based (LNP-mRNA) vaccines came into the spotlight as the first vaccines against SARS-CoV-2 virus to be applied worldwide. Long-known benefits of mRNA-based technologies consisting of relatively simple and fast engineering of mRNA encoding for antigen...

Descripción completa

Detalles Bibliográficos
Autor principal: Vlatkovic, Irena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8151051/
https://www.ncbi.nlm.nih.gov/pubmed/34068715
http://dx.doi.org/10.3390/biomedicines9050530

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8151051/
https://www.ncbi.nlm.nih.gov/pubmed/34068715
http://dx.doi.org/10.3390/biomedicines9050530

Ejemplares similares